The p53-MDM2 axis constitutes an ideal model with significant impact on cancer therapeutics [144] that may facilitate the understanding of various systems and interaction networks employing protein-mRNA interactions and refine predictive studies aiming to identify biomarkers of genetic diseases for translation research [47, 68, 145]. Here, MDM2 is linked to cancer.